骨成型蛋白受体1A抗体,Anti-BMPR1A/CD292抗体

“骨成型蛋白受体1A抗体,Anti-CD292抗体应有尽有 ”我公司拥有领先的细胞服务技术，先进的设备和专业的ELISA检测试剂盒、生物索标记、荧光索标记、酶标记等，广泛用于多种分析研究与技术测定。欢迎来电咨询，我们将竭诚为你服务！
抗体（antibody）指机体的免疫系统在抗原刺激下，由B淋巴细胞或记忆细胞增殖分化成的浆细胞所产生的、可与相应抗原发生特异性结合的免疫球蛋白。主要分布在血清中，也分布于组织液及外分泌液中。
产品规格：0.1ml/0.2ml
中文名称：骨成型蛋白受体1A抗体   
英文名称：Anti-BMPR1A/CD292  
产品编号：byk-1509R  
产品用途：科研实验
性 状： Lyophilized or Liquid
浓 度： 1mg/1ml
亚 型： IgG
贮 存： 贮存于-20℃.
相关标记: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
骨成型蛋白受体1A抗体,Anti-CD292抗体应有尽有 相关产品：
Anti-HBsAg(Human Hepatitis B Surface Antigen Monoclonal Antibody)  小鼠抗人乙肝表面抗原抗体
Anti-HBsAg(Human Hepatitis B Surface Antigen Monoclonal Antibody)  小鼠抗人乙肝表面抗原抗体（检测）
Anti-HBcAg(Human Hepatitis B core Antigen)monoclonal antibody  小鼠抗人乙肝核心抗原抗体
Anti-HBeAg( HBeAg Mouse Monoclonal Antibody)(1)  小鼠抗人乙肝e抗原抗体（1）
Anti-HBeAg(Mouse human Anti-HbeAg Monoclonal Antibody)(2)  小鼠抗人乙肝e抗原抗体（2）
Anti-VWCE/URG11(von Willebrand factor C and EGF domain-containing)  乙型肝炎病毒X蛋白(HBxAg)抗体
Anti-URGCP/URG4(Up-regulator of cell proliferation)N terminal  乙型肝炎病毒X蛋白(HBxAg)抗体N端
Anti-URGCP/URG4(Up-regulator of cell proliferation)C terminal  乙型肝炎病毒X蛋白(HBxAg)抗体C端
Anti-HBV/pre S1/S2 protein  抗乙肝病毒pre S1/乙肝病毒pre S2抗体
Anti-β-HCG(Mouse Anti-Human Chorionic Gonadotropin β Monoclonal Antibody）  小鼠抗人β 亚基人绒毛膜促性腺激素单抗
骨成型蛋白受体1A抗体,Anti-CD292抗体应有尽有 产品详情：
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.